Showing results (1781-1790 of 1,810) with videos related to
Sort By:
Pageof 181
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|December 28, 2025
[Practice guideline for standardized construction of ambulatory surgery in pediatric otorhinolaryngology and head and neck surgery]Dabo Liu, Xiaoyan Li, Biao Chen, et al.Journal of Translational Medicine|March 4, 2023
The spatiotemporal matching pattern of Ezrin/Periaxin involved in myoblast differentiation and fusion and Charcot-Marie-Tooth disease-associated muscle atrophyRuo-Nan Zhang, Xin Bao, Yun Liu, et al.Nature Communications|December 31, 2024
Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphomaJulia Paczkowska, Ming Tang, Kyle T Wright, et al.Science (New York, N.Y.)|December 23, 2021
Semiconductor nanochannels in metallic carbon nanotubes by thermomechanical chirality alterationDai-Ming Tang, Sergey V Erohin, Dmitry G Kvashnin, et al.Scientific Reports|January 9, 2023
Continuous exposure to isoprenaline reduced myotube size by delaying myoblast differentiation and fusion through the NFAT-MEF2C signaling pathwayJing Yue, Wei Xu, Li Xiang, et al.JHEP Reports : Innovation in Hepatology|March 14, 2022
Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiencyChao Zheng Li, Hiromi Ogawa, Soon Seng Ng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2018
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in <i>EGFR</i>-Mutant NSCLCXiuning Le, Sonam Puri, Marcelo V Negrao, et al.Cancer Cell|March 26, 2019
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal CancerWenting Liao, Michael J Overman, Adam T Boutin, et al.Nature Genetics|October 1, 2021
Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress responseKevin C Johnson, Kevin J Anderson, Elise T Courtois, et al.Cell Reports|July 21, 2021
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategyChristopher J Terranova, Ming Tang, Mayinuer Maitituoheti, et al.Pageof 181